SIC
ACIU icon

SJS Investment Consulting’s AC Immune ACIU Stock Holding History

SJS Investment Consulting’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$374 – 1549
2025
Q1 		$374 Hold
200
– – ﹤0.01% 1331
2024
Q4 		$540 Hold
200
– – ﹤0.01% 1213
2024
Q3 		$756 Hold
200
– – ﹤0.01% 1167
2024
Q2 		$798 Buy
+200
New +$662 ﹤0.01% 1117

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SJS Investment Consulting's ACIU Position: Q2 2025 in Review

SJS Investment Consulting sold out of AC Immune (ACIU) in Q2 2025, closing a stake of 200 shares — an estimated $374 sold.

SJS Investment Consulting first reported a position in ACIU in Q2 2024 and held it in 4 quarters. The position peaked at $798 in Q2 2024. 42 funds tracked by Wall St. Rank hold ACIU as of Q2 2025.

  • SJS Investment Consulting reported no remaining AC Immune position as of Q2 2025 after selling out during the quarter.
  • SJS Investment Consulting sold 200 AC Immune shares in Q2 2025, an estimated $374.
  • SJS Investment Consulting first reported a position in AC Immune in Q2 2024 and held it in 4 quarters.
  • SJS Investment Consulting's AC Immune position peaked at $798 in Q2 2024.
  • 42 funds tracked by Wall St. Rank held AC Immune as of Q2 2025.

Based on SJS Investment Consulting's 13F filing for Q2 2025, filed 15 Jul 2025.